Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Combined With Chemotherapy for Recurrent/Refractory Yolk Sac Tumor in Children
NCT06341998Phase 3Completed
- Sponsor
- Shandong First Medical University
- Start
- Jun 2020
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in yolk sac tumor, sponsored by Shandong First Medical University. Started Jun 2020; status: completed.
02
Drugs
sirolimus
03
Conditions
yolk sac tumor
Beyond the preview
Go deeper on NCT06341998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06341998.